Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1984 Oct;47(10):1087–1090. doi: 10.1136/jnnp.47.10.1087

Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.

J B Chalk, K Ridgeway, T Brophy, J D Yelland, M J Eadie
PMCID: PMC1028038  PMID: 6502166

Abstract

Plasma concentration-time data after oral and intravenous administration of dexamethasone have been subjected to pharmacokinetic analysis in six neurological or neurosurgical patients taking the steroid with phenytoin, and in nine patients (one studied twice) taking dexamethasone without phenytoin. An additional patient was studied before and during phenytoin intake. Apparent volume of distribution was similar in the two groups, but the group treated with phenytoin had an almost statistically significantly shorter dexamethasone mean terminal half-life, an approximately trebled mean plasma clearance, and a mean oral bioavailability of the steroid of only 33%, compared with a mean 84% oral bioavailability in those not receiving phenytoin. To achieve a given plasma dexamethasone concentration, patients treated with the steroid and phenytoin may need oral dexamethasone doses several times those required by patients not receiving phenytoin.

Full text

PDF
1087

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brophy T. R., McCafferty J., Tyrer J. H., Eadie M. J. Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients. Eur J Clin Pharmacol. 1983;24(1):103–108. doi: 10.1007/BF00613935. [DOI] [PubMed] [Google Scholar]
  2. Cham B. E., Sadowski B., O'Hagan J. M., de Wytt C. N., Bochner F., Eadie M. J. High performance liquid chromatographic assay of dexamethasone in plasma and tissue. Ther Drug Monit. 1980;2(4):373–377. [PubMed] [Google Scholar]
  3. Jubiz W., Meikle A. W., Levinson R. A., Mizutani S., West C. D., Tyler F. H. Effect of diphenylhydantoin on the metabolism of dexamethasone. N Engl J Med. 1970 Jul 2;283(1):11–14. doi: 10.1056/NEJM197007022830103. [DOI] [PubMed] [Google Scholar]
  4. Tsuei S. E., Moore R. G., Ashley J. J., McBride W. G. Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults. J Pharmacokinet Biopharm. 1979 Jun;7(3):249–264. doi: 10.1007/BF01060016. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES